AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL...
Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hosp...
AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease ( Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital )
30 Apr 2009
AACR 2009: Membrane microfilter device for capture and characterisation of circu...
Anthony Williams - Keck School of Medicine, University of Southern California
AACR 2009: Membrane microfilter device for capture and characterisation of circulating tumour cells ( Anthony Williams - Keck School of Medicine, University of Southern California )
30 Apr 2009
AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia
Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medic...
AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia ( Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medicine, USA )
30 Apr 2009
Bacteria as agents to initiate potent anti-tumour activity
Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of ...
Bacteria as agents to initiate potent anti-tumour activity ( Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan )
31 Mar 2009
Managing cardiotoxicity while treating cancer
Dr Carlo Cipolla - Director of the Cardioncology Division, European Institute of...
Managing cardiotoxicity while treating cancer ( Dr Carlo Cipolla - Director of the Cardioncology Division, European Institute of Oncology, Milan )
18 Mar 2009
Azacitidine for Myelodysplastic Syndrome
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Cente...
Azacitidine for Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009
Effects of Myelodysplastic Syndrome
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Cente...
Effects of Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009
How azacitidine works
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Cente...
How azacitidine works ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009
Myelodysplastic Syndromes and Acute Myeloid Leukaemia
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Cente...
Myelodysplastic Syndromes and Acute Myeloid Leukaemia ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009
ECCO 15 - ESMO 34 Executive Scientific Programme Committee
ECCO-ESMO Roundtable discussion - Full Version
ECCO 15 - ESMO 34 Executive Scientific Programme Committee ( ECCO-ESMO Roundtable discussion - Full Version )
16 Feb 2009
Clinical Requirements Regarding In Silico Oncology
Professor Norbert Graf, Director of Oncology and Haematology Clinic, University ...
Clinical Requirements Regarding In Silico Oncology ( Professor Norbert Graf, Director of Oncology and Haematology Clinic, University of Saarland )
23 Jan 2009
Breast Cancer Cell Apoptosis
Dr Anthony Letai, Assistant Professor of Medicine, Haematologic Malignancies, Da...
Breast Cancer Cell Apoptosis ( Dr Anthony Letai, Assistant Professor of Medicine, Haematologic Malignancies, Dana-Farber Cancer Institute )
9 Jan 2009